CLINICAL_TRIALS
trial_result
· 2014-02-03
Clinical Trial Update: A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED) [Phase 2]
Summary
Phase 2 study of the investigational drug MK-0873-012 in rheumatoid arthritis has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-02-03